InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/08/2019 10:00:42 AM

Monday, April 08, 2019 10:00:42 AM

Post# of 9289
News: $NAVB Navidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business Updates

Company Will Host Conference Call at 5:00 p.m. (ET) on Monday, April 8, 2019 Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutic...

In case you are interested https://marketwirenews.com/news-releases/navidea-biopharmaceuticals-receives-fda-feedback-regarding-rheumatoid-arthritis-clinical-trial-design-and-provides-business-updates-7962016.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News